Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development

[1]  David J. Miller,et al.  Novel Indole-2-Carboxamide Compounds Are Potent Broad-Spectrum Antivirals Active against Western Equine Encephalitis Virus In Vivo , 2014, Journal of Virology.

[2]  S. Weaver.  Arrival of Chikungunya Virus in the New World: Prospects for Spread and Impact on Public Health , 2014, PLoS neglected tropical diseases.

[3]  David J. Miller,et al.  Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria , 2013, PloS one.

[4]  David J. Miller,et al.  Optimization of novel indole-2-carboxamide inhibitors of neurotropic alphavirus replication. , 2013, Journal of medicinal chemistry.

[5]  A. Powers,et al.  Liposome-Antigen-Nucleic Acid Complexes Protect Mice from Lethal Challenge with Western and Eastern Equine Encephalitis Viruses , 2013, Journal of Virology.

[6]  A. Powers,et al.  Molecular Determinants of Mouse Neurovirulence and Mosquito Infection for Western Equine Encephalitis Virus , 2013, PloS one.

[7]  Ann M. Powers,et al.  Bioluminescent Imaging and Histopathologic Characterization of WEEV Neuroinvasion in Outbred CD-1 Mice , 2013, PloS one.

[8]  David J. Miller,et al.  Neurotropic Arboviruses Induce Interferon Regulatory Factor 3-Mediated Neuronal Responses That Are Cytoprotective, Interferon Independent, and Inhibited by Western Equine Encephalitis Virus Capsid , 2012, Journal of Virology.

[9]  David J. Miller,et al.  Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis. , 2012, Journal of medicinal chemistry.

[10]  K. E. Steele,et al.  REVIEW PAPER , 2010, Veterinary pathology.

[11]  S. Paessler,et al.  Encephalitic alphaviruses. , 2010, Veterinary microbiology.

[12]  A. Brault,et al.  Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. , 2009, The Journal of general virology.

[13]  D. Smee,et al.  Effect of T-705 treatment on western equine encephalitis in a mouse model. , 2009, Antiviral research.

[14]  David J. Miller,et al.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses. , 2009, The Journal of infectious diseases.

[15]  E. Wang,et al.  Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence. , 2008, Virology.

[16]  David J. Miller,et al.  Maturation-dependent responses of human neuronal cells to western equine encephalitis virus infection and type I interferons. , 2008, Virology.

[17]  N. Prow,et al.  Neuroprotective Interventions Targeting Detrimental Host Immune Responses Protect Mice From Fatal Alphavirus Encephalitis , 2007, Journal of neuropathology and experimental neurology.

[18]  Wei-Gang Hu,et al.  Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine. , 2007, Vaccine.

[19]  R. Sidwell,et al.  Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. , 2007, Virology.

[20]  Wei-Gang Hu,et al.  Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. , 2006, The Journal of general virology.

[21]  M. Lackemeyer,et al.  Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. , 2005, The Journal of infectious diseases.

[22]  S. Rivest,et al.  Estradiol Is Required for a Proper Immune Response to Bacterial and Viral Pathogens in the Female Brain 1 , 2005, The Journal of Immunology.

[23]  D. Griffin,et al.  Neuronal cell death in alphavirus encephalomyelitis. , 2005, Current topics in microbiology and immunology.

[24]  J. Rothstein,et al.  Glutamate receptor antagonists protect from virus‐induced neural degeneration , 2004, Annals of neurology.

[25]  D. Griffin,et al.  Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. , 2003, Virology.

[26]  D. Griffin,et al.  Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis , 2002, Journal of Neuroimmunology.

[27]  D. Griffin,et al.  Genetic Control of Neuroadapted Sindbis Virus Replication in Female Mice Maps to Chromosome 2 and Associates with Paralysis and Mortality , 2001, Journal of Virology.

[28]  D. Griffin,et al.  Differences between C57BL/6 and BALB/cBy Mice in Mortality and Virus Replication after Intranasal Infection with Neuroadapted Sindbis Virus , 2000, Journal of Virology.

[29]  D. Griffin,et al.  The Role of CD8+ T Cells and Major Histocompatibility Complex Class I Expression in the Central Nervous System of Mice Infected with Neurovirulent Sindbis Virus , 2000, Journal of Virology.

[30]  D. Griffin,et al.  Control of Sindbis Virus Infection by Antibody in Interferon-Deficient Mice , 2000, Journal of Virology.

[31]  R. Johnston,et al.  Alpha/Beta Interferon Protects Adult Mice from Fatal Sindbis Virus Infection and Is an Important Determinant of Cell and Tissue Tropism , 2000, Journal of Virology.

[32]  J. Goldman,et al.  Resistance of Interleukin-1β-Deficient Mice to Fatal Sindbis Virus Encephalitis , 1999, Journal of Virology.

[33]  William Slikker,et al.  Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration , 1997, Brain Research.

[34]  M. Barna,et al.  Sex differences in susceptibility to viral infection of the central nervous system , 1996, Journal of Neuroimmunology.

[35]  S. Wesselingh,et al.  Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis , 1996, Journal of virology.

[36]  J. Peterson,et al.  BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease , 1994, Journal of Neuroimmunology.

[37]  C. Calisher.  Medically important arboviruses of the United States and Canada , 1994, Clinical Microbiology Reviews.

[38]  J. H. Strauss,et al.  Western equine encephalitis virus is a recombinant virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. J. Cooper,et al.  Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice , 1986, Journal of virology.

[40]  A. Andersen,et al.  Influence of Sex and Age on Natural Resistance to St. Louis Encephalitis Virus Infection in Mice , 1974, Infection and immunity.

[41]  H. McFarland,et al.  Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. , 1972, The Journal of infectious diseases.

[42]  B. Rozdilsky,et al.  Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965. , 1968, Canadian Medical Association journal.

[43]  R. Hanson,et al.  Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards. , 1967, Science.

[44]  H. Grell.  Equine Encephalomyelitis , 1941, Research program. United States. Army. Medical Department.

[45]  R. Wyckoff,et al.  Equine Encephalomyelitis in Monkeys , 1939, The Journal of Immunology.

[46]  E. Hurst.  Infection of the rhesus monkey (Macaca mulatta) and the guinea‐pig with the virus of equine encephalomyelitis , 1936 .

[47]  K. Meyer,et al.  THE ETIOLOGY OF EPIZOOTIC ENCEPHALOMYELITIS OF HORSES IN THE SAN JOAQUIN VALLEY, 1930. , 1931, Science.